Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Tancini

Showing results (61-70 of 218) with videos related to

Pageof 22
Sort By:
Breast Cancer Research and Treatment|January 1, 1981
Adjuvant CMF effect on site of first recurrence, and appropriate follow-up intervals, in operable breast cancer with positive axillary nodesP Valagussa, J D Tess, A Rossi, et al.
Tumori|May 1, 1973
[Response and survival after sequential monochemotherapy in malignant lymphocytic and histocytic lymphoma]S Monfardini, G Tancini, M Gasparini, et al.
Journal of Biological Regulators and Homeostatic Agents|January 1, 1995
Correlation between pretreatment serum levels of neopterin and response to interleukin-2 immunotherapy in cancer patientsP Lissoni, S Barni, A Ardizzoia, et al.
European Urology|April 15, 2000
Paradoxical stimulation of prolactin secretion by L-dopa in metastatic prostate cancer and its possible role in prostate-cancer-related hyperprolactinemiaP Lissoni, M Mandalà, F Rovelli, et al.
The International Journal of Biological Markers|April 1, 1995
Zinc levels in serum during subcutaneous interleukin-2 immunotherapy of cancerP Lissoni, V Arosio, E Mocchegiani, et al.
Cancer Treatment Reports|September 1, 1976
Sequential laparoscopy and laparotomy combined with bone marrow biopsy in staging Hodgkin's diseaseG Beretta, P Spinelli, F Rilke, et al.
Tumori|December 31, 1988
Increased level of soluble interleukin-2 receptor in advanced solid tumors: a preliminary studyF Rovelli, P Lissoni, S Crispino, et al.
Oncology|January 1, 1991
Clinical results with the pineal hormone melatonin in advanced cancer resistant to standard antitumor therapiesP Lissoni, S Barni, G Cattaneo, et al.
Tumori|April 30, 1992
Intracavitary administration of interleukin-2 as palliative therapy for neoplastic effusionsP Lissoni, S Barni, A Ardizzoia, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 1, 1995
Intracavitary therapy of neoplastic effusions with cytokines: comparison among interferon alpha, beta and interleukin-2P Lissoni, S Barni, G Tancini, et al.
Pageof 22

Showing results (61-70 of 218) with videos related to

Sort By:
Pageof 22
Breast Cancer Research and Treatment|January 1, 1981
Adjuvant CMF effect on site of first recurrence, and appropriate follow-up intervals, in operable breast cancer with positive axillary nodesP Valagussa, J D Tess, A Rossi, et al.
Tumori|May 1, 1973
[Response and survival after sequential monochemotherapy in malignant lymphocytic and histocytic lymphoma]S Monfardini, G Tancini, M Gasparini, et al.
Journal of Biological Regulators and Homeostatic Agents|January 1, 1995
Correlation between pretreatment serum levels of neopterin and response to interleukin-2 immunotherapy in cancer patientsP Lissoni, S Barni, A Ardizzoia, et al.
European Urology|April 15, 2000
Paradoxical stimulation of prolactin secretion by L-dopa in metastatic prostate cancer and its possible role in prostate-cancer-related hyperprolactinemiaP Lissoni, M Mandalà, F Rovelli, et al.
The International Journal of Biological Markers|April 1, 1995
Zinc levels in serum during subcutaneous interleukin-2 immunotherapy of cancerP Lissoni, V Arosio, E Mocchegiani, et al.
Cancer Treatment Reports|September 1, 1976
Sequential laparoscopy and laparotomy combined with bone marrow biopsy in staging Hodgkin's diseaseG Beretta, P Spinelli, F Rilke, et al.
Tumori|December 31, 1988
Increased level of soluble interleukin-2 receptor in advanced solid tumors: a preliminary studyF Rovelli, P Lissoni, S Crispino, et al.
Oncology|January 1, 1991
Clinical results with the pineal hormone melatonin in advanced cancer resistant to standard antitumor therapiesP Lissoni, S Barni, G Cattaneo, et al.
Tumori|April 30, 1992
Intracavitary administration of interleukin-2 as palliative therapy for neoplastic effusionsP Lissoni, S Barni, A Ardizzoia, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 1, 1995
Intracavitary therapy of neoplastic effusions with cytokines: comparison among interferon alpha, beta and interleukin-2P Lissoni, S Barni, G Tancini, et al.
Pageof 22